Not Tagged
USWM, LLC
[]
the open-label infus-on study was the first to use spn-830 in the u.s., where researchers hope the therapy is soon made available. #parkinsonsdiseaseresearch #parkinsonsdisease #livingwithparkinsons 
We exist to bring you science, research and clinical news about Parkinson's disease. We are a free digital publication dedicated to the patient community.